Today is White Out Cancer Day. In order to honor Cancer Immunotherapy Month, The Cancer Research Institute is encouraging everyone to wear white today. Immunotherapy is a promising field in cancer research and treatment that [...]
Immunotherapy treatments garnered a great deal of attention at the Annual Meeting of the American Society of Clinical Oncology (ASCO). This article from the New York Times discusses this form of treatment and its [...]
Life Raft Group member, Diana Smith was recently featured in an article in Clarksville Tennessee’s Leaf Chronicle about GIST. The article quotes Assistant Program Director, Mildred Menos and provides helpful information about GIST sure to [...]
Join The Life Raft Group for a GIST Q&A with LRG Science Director Jerry Call to be held on April 28. Jerry will answer all of your GIST questions live!
There are a number of side effects caused by GIST medications. Altered taste syndrome is a common and annoying side effect for many GIST patients. Gleevec and Sutent have a bitter taste associated with them, like [...]
Research!America and the Pancreatic Cancer Action Network held a meeting in New York this year to discuss ways to restructure clinical trials to find a cure for cancer.
As of April 01, 2014 All Pfizer Patient Assistance Programs have been consolidated into one program called Pfizer RxPathwaysTM.
Indian generic drug quality has been questioned recently by a number of U.S. doctors. The concern stems from FDA recalls and import bans.
A recent clinical trial found that 1 year of adjuvant imatinib was able to increase recurrence-free survival. Keep reading to learn more.
The LRG helped fund research by the University of Pittsburgh Cancer Institute (UPCI) to screen a library of FDA-approved anticancer drugs that previously wouldn’t have been considered as a treatment for GIST. UPCI scientists have been surprised at [...]
